Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2019
Operating activities
Net income (loss)	$ (2,070)	$ (2,582)	$ 3,280	$ (7,075)
Adjustments to reconcile income (loss) from operations to net cash provided by operating activities
Depreciation	722	854	2,160	1,774
Amortization of intangibles	521	608	1,490	1,900
Amortization of developed technology		3,100		9,432
Deferred income taxes			(499)	(313)
Share-based compensation	6,630	1,329	9,312	3,156
Changes in operating assets and liabilities			(659)	(3,601)
Net cash provided by operating activities			15,084	5,273
Investing activities
Capital expenditures			(1,076)	(3,009)
Additional investments in corporate-owned life insurance policies			(2)	(26)
Net cash used in investing activities			(1,078)	(3,035)
Financing activities
Repurchase of common shares to satisfy employee tax withholding			(1,069)	(1,053)
Series A convertible preferred stock issuance proceeds, net of issuance costs			33,969
Payment of preferred stock dividends			(1,117)
Principal payments under long-term obligations			(18)	(18)
Net cash provided by (used in) financing activities			31,765	(1,071)
Effect of exchange rate changes on cash			184	(33)
Net increase in cash and cash equivalents			45,955	1,134
Cash and cash equivalents at beginning of period			46,653	40,771
Cash and cash equivalents at end of period	$ 92,608	$ 41,905	$ 92,608	$ 41,905